Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:human
|
| gptkbp:awardReceived |
gptkb:Fellow_of_the_Royal_Society
gptkb:order_of_merit |
| gptkbp:birthDate |
1957
|
| gptkbp:birthPlace |
gptkb:United_Kingdom
|
| gptkbp:education |
gptkb:University_of_Cambridge
gptkb:University_of_Oxford |
| gptkbp:employer |
gptkb:Wellcome_Trust_Sanger_Institute
|
| gptkbp:fieldOfWork |
cancer research
genetics |
| https://www.w3.org/2000/01/rdf-schema#label |
Sir Michael Stratton
|
| gptkbp:knownFor |
cancer genomics
identification of BRCA2 gene |
| gptkbp:memberOf |
gptkb:Academy_of_Medical_Sciences
gptkb:Royal_Society |
| gptkbp:nationality |
British
|
| gptkbp:occupation |
gptkb:cancer
gptkb:scientist biologist |
| gptkbp:position |
Director of Wellcome Trust Sanger Institute
|
| gptkbp:bfsParent |
gptkb:Royal_Academy_of_Engineering_(UK)
|
| gptkbp:bfsLayer |
7
|